Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on Calix, Raises Price Target to $70

Needham Maintains Buy on Calix, Raises Price Target to $70

Needham analyst Ryan Koontz maintains Calix (NYSE:CALX) with a Buy and raises the price target from $63 to $70.

byBenzinga Newsdesk

October 18, 2022

1 minute read

Needham analyst Ryan Koontz maintains Calix (NYSE:CALX) with a Buy and raises the price target from $63 to $70.

Analyst Ratings

Analyst Expectations for Nu Skin Enterprises’s Future

By Benzinga Insights

October 16, 5:00 PM

Nu Skin Enterprises (NYSE:NUS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

NUS

BTIG Upgrades Avrobio to Buy, Announces $4 Price Target

By Benzinga Newsdesk

December 8, 6:22 AM

BTIG analyst Yun Zhong upgrades Avrobio (NASDAQ:AVRO) from Neutral to Buy and announces $4 price target.

AVRO

From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors

By Robert Kuczmarski

August 28, 8:48 AM

Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions.

BLCO

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $40

By Benzinga Newsdesk

October 27, 1:48 PM

Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and lowers the price target from $50 to $40.

CSV

Needham Maintains Buy on Calix, Raises Price Target to $70

Related Posts

Analyst Expectations for Nu Skin Enterprises’s Future

BTIG Upgrades Avrobio to Buy, Announces $4 Price Target

From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $40